Pharmaceuticals market research reports by GlobalData

• Yakult Honsha Co Ltd (2267) - Financial and Strategic SWOT Analysis Review

  Apr 29, 2024  |  Published by: GlobalData  |  USD 125

  Yakult Honsha Co Ltd (2267) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne ... Read More

• Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review

  Apr 29, 2024  |  Published by: GlobalData  |  USD 125

  Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we ... Read More

• West Pharmaceutical Services Inc (WST) - Financial and Strategic SWOT Analysis Review

  Apr 29, 2024  |  Published by: GlobalData  |  USD 125

  West Pharmaceutical Services Inc (WST) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths ... Read More

• ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review

  Apr 29, 2024  |  Published by: GlobalData  |  USD 125

  ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a ... Read More

• Post-operative Pain (POP) - Competitive Landscape

  Apr 25, 2024  |  Published by: GlobalData  |  USD 3,495

  Post-operative Pain (POP) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in POP therapeutics. In 2024, more than 34,000,000 incident cases of POP are anticipated in the 16 countries covered in GlobalData’s epidemiology for ... Read More

• Friedreich Ataxia (FRDA) - Competitive Landscape

  Apr 25, 2024  |  Published by: GlobalData  |  USD 3,495

  Friedreich Ataxia (FRDA) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in FRDA therapeutics. More than 54,000 diagnosed prevalent cases of FRDA are anticipated in 2024 in the 16 countries covered in GlobalData’s epidemiol ... Read More

• Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024 provides an overview of Chronic Lymphocytic Leukemia (CLL) Clinical trials scenario. This report provides top ... Read More

• Mycosis Fungoides - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Mycosis Fungoides - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Mycosis Fungoides - Global Clinical Trials Review, 2024 provides an overview of Mycosis Fungoides Clinical trials scenario. This report provides top line data relating to the clinical trials on Mycos ... Read More

• Epilepsy - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Epilepsy - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Epilepsy - Global Clinical Trials Review, 2024 provides an overview of Epilepsy Clinical trials scenario. This report provides top line data relating to the clinical trials on Epilepsy. Report includes an ove ... Read More

• Pulmonary Tuberculosis - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Pulmonary Tuberculosis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Pulmonary Tuberculosis - Global Clinical Trials Review, 2024 provides an overview of Pulmonary Tuberculosis Clinical trials scenario. This report provides top line data relating to the clinical ... Read More

• Digital Marketing Trends in Type 2 Diabetes - April 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 1,950

  Digital Marketing Trends in Type 2 Diabetes - April 2024 Summary Novo Nordisk’s Ozempic.com achieved the highest total traffic across branded type 2 diabetes (T2D) patient sites in the US, at 16,000,000 visitors from April 2023 to March 2024. This was followed by Rybelsus.com with over 9,000,000 vis ... Read More

• Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024 provides an overview of Hospital Acquired Pneumonia (HAP) Clinical trials scenario. This report provides top li ... Read More

• Juvenile Macular Degeneration (Stargardt Disease) - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Juvenile Macular Degeneration (Stargardt Disease) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Juvenile Macular Degeneration (Stargardt Disease) - Global Clinical Trials Review, 2024 provides an overview of Juvenile Macular Degeneration (Stargardt Disease) Clini ... Read More

• Decompensated Cirrhosis - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Decompensated Cirrhosis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Decompensated Cirrhosis - Global Clinical Trials Review, 2024 provides an overview of Decompensated Cirrhosis Clinical trials scenario. This report provides top line data relating to the clinic ... Read More

• Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024 provides an overview of Wet (Neovascular / Exudative) Macular Degeneration Cl ... Read More

• Amyloidosis - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Amyloidosis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Amyloidosis - Global Clinical Trials Review, 2024 provides an overview of Amyloidosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report inc ... Read More

• Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2024 provides an overview of Systemic Sclerosis (Scleroderma) Clinical trials scenario. This report provides top line ... Read More

• New Prescription - Generative AI meets Healthcare (Vol. 2)

  Apr 22, 2024  |  Published by: GlobalData  |  USD 995

  New Prescription - Generative AI meets Healthcare (Vol. 2) Summary GlobalData's latest Innovation Radar report New Prescription: Generative AI Meets Healthcare (Vol. 2), expands upon its predecessor and digs further into the transformative capabilities of generative AI within the pharmaceutical and ... Read More

• Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs

  Apr 19, 2024  |  Published by: GlobalData  |  USD 295

  Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs Summary This comprehensive conversation analysis report delves into the most popular weight loss drugs on Reddit in the last six months (October 1st, 2023, to March 31st, 2024), offering a nuanced understanding of their prominence and po ... Read More

• Digital Marketing Trends in Inflammatory Bowel Disease - April 2024

  Apr 17, 2024  |  Published by: GlobalData  |  USD 1,950

  Digital Marketing Trends in Inflammatory Bowel Disease - April 2024 Summary AbbVie’s Skyrizi.com achieved the highest total traffic across inflammatory bowel disease (IBD) patient sites in the US, with over 1.8 million visitors from March 2023 to February 2024. This was followed by AbbVie’s Rinvoq.c ... Read More

• Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033

  Apr 16, 2024  |  Published by: GlobalData  |  USD 3,995

  Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033 Summary Methicillin-resistant Staphylococcus aureus (MRSA) is a virulent, antibiotic-resistant bacteria that is associated with considerable morbidity and mortality (Vázquez-Sánchez et al., 2022). MRSA can ... Read More

• Thematic Intelligence: Net Zero Strategies in the Pharmaceutical Sector

  Apr 16, 2024  |  Published by: GlobalData  |  USD 995

  Thematic Intelligence: Net Zero Strategies in the Pharmaceutical Sector Thematic Intelligence: Net Zero Strategies in the Pharmaceutical Sector Summary Companies achieve net zero emissions by cutting greenhouse gas emissions to as close to zero as possible, with any remaining emissions then “offset. ... Read More

• New Drug Approvals and Their Contract Manufacture - 2024 Edition

  Apr 16, 2024  |  Published by: GlobalData  |  USD 4,995

  New Drug Approvals and Their Contract Manufacture - 2024 Edition Summary This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called CMO Sco ... Read More

• Acne Vulgaris (AV) - Competitive Landscape

  Apr 15, 2024  |  Published by: GlobalData  |  USD 3,495

  Acne Vulgaris (AV) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AV therapeutics. GlobalData epidemiologists estimated more than 403 million diagnosed prevalent cases of AV in 2023 in the 16 countries covered in Global ... Read More

• Colibri Heart Valve LLC - Product Pipeline Analysis, 2023 Update

  Apr 08, 2024  |  Published by: GlobalData  |  USD 750

  Summary Colibri Heart Valve LLC (Colibri Heart Valve) is a privately held medical device company that researches and develops novel, patent-protected, and structural heart technologies. The company’s products include Colibri transcatheter aortic valve implantation system, pipeline products and clini ... Read More

< prev 20 21 22 23 24 25 26 27 28 29 next >